OGN News & Events

Organon announced that it has entered into an agreement to exclusively license global rights to Miudella, Sebela Pharmaceuticals' hormone-free copper intrauterine device contraceptive. The effectiveness of this transaction is subject to review under the Hart-Scott-Rodino Antitrust Improvements Act and to FDA approval of Miudella's alternate supply chain entities and certain other conditions. Miudella was approved by the FDA on February 24, 2025, for the prevention of pregnancy in females of reproductive potential for up to three years and is not yet commercially available. Under the terms of the agreement, Organon will pay $27.5M at closing, with potential sales-based milestone payments of up to $505M, as well as tiered double-digit royalties based on net sales.

The major averages were broadly lower amid concerns over technology profits after a tepid margin outlook from Cisco Systems, whose forecast underscored that higher memory-chip prices are taking a toll. Looking to commodities, gold scaled back after yesterday's gains, slipping over 2%. Oil was also sharply lower following the EIA natural gas storage data.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Ciscoprovided areport for Q2 and raised its quarterly dividendMcDonald'sreportedand provided its outlook for 2026FedExsaid it now sees itsof $3.99 and that its planned FedEx Freight spinoff is on track for June 1Baxterreportedand provided downbeat FY26 earnings guidancePresident Donald Trump ordered the Pentagon to2. WALL STREET CALLS:Shopifyto Outperform at Mizuho and to Buy at TD CowenDeutsche BankBorgWarnerto Buy on "pivotal shift" to AIRBCHumanaon Medicare Advantage cost pressureKraft Heinzto Underweight at JPMorganCoinbaseto Sell at Monness Crespi ahead of Q4 report3. AROUND THE WEB:Apple'slong-planned update of its Siri virtual assistant has run into some issues during recent testing, possibly delaying the release of several highly anticipated functions, Bloomberg reportsAdam Mosseri, the CEO of Meta'sInstagram, on Wednesday disputed claims that the platform prioritized making money over the mental health of young users in a landmark tech addiction case, saying social media is not "clinically addictive" and that Meta was careful to test features used by young people, NY Times saysAeroVironment'sLOCUST laser counter-drone weapon system was deployed by the U.S. Army on Wednesday near El Paso International Airport, Reuters reportsNaveen Mallela, JPMorgan'sglobal co-head of blockchain unit Kinexys, is leaving after 11 years at the bank, Bloomberg reportsChina's ByteDance is in talks with Samsungto manufacture an AI chip, Reuters says4. MOVERS:Novocureincreases in New York afterby the FDA to treat pancreatic cancerCrocsgains afterand providing guidance for Q1 and FY26Fastlyand Cognexhigher afterIconfalls in New York after providing an update on itsinto accounting practices and withdrawing its previously issued FY25 guidanceEnergy Vaultlower after announcing aand providing guidance for Q45. EARNINGS/GUIDANCEIPG, with EPS and revenue beating consensusRestaurant Brands, with CEO Josh Kobza commenting, "As we enter 2026, I'm encouraged by the stronger, more focused foundation we've built for the long term"Phiniaand provided guidance for FY26Organon, with EPS missing consensusMelco Resorts, with CEO Lawrence Ho commenting, "2025 was a year of growth and recovery"INDEXES:Near midday, the Dow was down 1.10%, or 553.18, to 49,568.22, the Nasdaq was down 1.54%, or 355.58, to 22,710.89, and the S&P 500 was down 1.16%, or 80.39, to 6,861.08.

Sees FY26 adjusted EBITDA $1.9B. Sees FY26 tax rate 27.5%-29.5%. The company said, "For full year 2026, the company expects to achieve revenue of approximately $6.2 billion and Adjusted EBITDA of approximately $1.9 billion; both measures in-line with 2025 performance. The company expects that the annual revenue foregone with the sale of the JADA system will be approximately offset by favorable currency translation, resulting in constant currency revenue growth about flat with prior year, pro forma for the JADA system divestiture."